Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease. (2018)

First Author: Daroszewska A
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1242/dmm.035576

PubMed Identifier: 30154079

Publication URI: http://europepmc.org/abstract/MED/30154079

Type: Journal Article/Review

Volume: 11

Parent Publication: Disease models & mechanisms

Issue: 9

ISSN: 1754-8403